纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | AVBP | ArriVent BioPharma Inc | 136.83 | 0.09% |
| 2024-12-31 | COLL | Collegium Pharmaceutical Inc | 140.83 | 0.09% |
| 2024-12-31 | PCRX | Pacira BioSciences Inc | 132.59 | 0.09% |
| 2024-12-31 | REPL | Replimune Group Inc | 142.04 | 0.09% |
| 2024-12-31 | ADPT | Adaptive Biotechnologies Corp | 134.85 | 0.09% |
| 2024-12-31 | AVXL | Anavex Life Sciences Corp | 138.81 | 0.09% |
| 2024-12-31 | GMAB | Genmab A/S ADR | 133.38 | 0.09% |
| 2024-12-31 | QURE | uniQure NV | 131.2 | 0.09% |
| 2024-12-31 | ETNB | 89bio Inc | 140.15 | 0.09% |
| 2024-12-31 | PLRX | Pliant Therapeutics Inc | 122.15 | 0.08% |
| 2024-12-31 | LENZ | LENZ Therapeutics Inc | 121.01 | 0.08% |
| 2024-12-31 | KNSA | Kiniksa Pharmaceuticals International plc-A | 125.32 | 0.08% |
| 2024-12-31 | CVAC | CureVac NV | 116.6 | 0.08% |
| 2024-12-31 | MRVI | Maravai LifeSciences Holdings Inc-A | 117.83 | 0.08% |
| 2024-12-31 | CRGX | Cargo Therapeutics Inc | 101.17 | 0.07% |
| 2024-12-31 | CSTL | Castle Biosciences Inc | 113.77 | 0.07% |
| 2024-12-31 | ERAS | Erasca Inc | 108.17 | 0.07% |
| 2024-12-31 | RLAY | Relay Therapeutics Inc | 105.11 | 0.07% |
| 2024-12-31 | CGEM | Cullinan Therapeutics Inc | 108.1 | 0.07% |
| 2024-12-31 | KURA | Kura Oncology Inc | 103.24 | 0.07% |
公告&资料
